Stratec (ETR:SBS) Trading 1.4% Higher – Should You Buy?

Stratec SE (ETR:SBSGet Free Report)’s share price traded up 1.4% during mid-day trading on Tuesday . The company traded as high as €18.48 and last traded at €18.46. 3,704 shares changed hands during trading, a decline of 41% from the average daily volume of 6,253 shares. The stock had previously closed at €18.20.

Stratec Stock Down 1.0%

The stock has a market capitalization of $215.53 million, a P/E ratio of 21.53, a P/E/G ratio of 10.43 and a beta of 0.80. The firm’s fifty day moving average is €17.51 and its 200-day moving average is €19.44. The company has a current ratio of 4.33, a quick ratio of 1.65 and a debt-to-equity ratio of 49.40.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.

Featured Stories

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.